Portfolio Update and Currency Management Activities – March 2026

The Intelligent Investor Equity Growth Fund – Active ETF, managed by InvestSMART Funds Management Limited, released its March 2026 portfolio holdings as part of a routine regulatory filing. The filing provides a snapshot of the fund’s equity exposure and hedging strategy, offering transparency for investors and market participants.

Equity Composition

  • Australian Focus: The fund maintains a concentration in Australian equities, consistent with its stated mandate to capture growth opportunities in the domestic market.
  • International Allocation: A modest allocation to international names remains, diversifying the portfolio’s exposure beyond the Australian market.

Sonic Healthcare Ltd.

  • Position Size: The fund holds a modest position in Sonic Healthcare Ltd., a leading Australian diagnostics and pathology company.
  • Investment Rationale: The disclosure does not elaborate on the strategic reasoning or performance expectations associated with this holding. Investors should note that the fund’s concentration on Australian equities suggests that the investment may align with broader sectoral or market‑timing considerations rather than a targeted thesis on Sonic Healthcare’s financial performance.

Currency Hedging Activity

  • Forward Agreement: The filing reports a currency forward agreement to sell U.S. dollars (USD) and purchase Australian dollars (AUD).
  • Objective: This arrangement reflects the fund’s ongoing management of foreign‑currency exposure. By locking in a future exchange rate, the fund seeks to mitigate adverse currency movements that could affect the valuation of its U.S. dollar denominated assets relative to its Australian dollar liabilities or holdings.

Regulatory Context

  • Disclosure Requirements: The update aligns with the Australian Securities and Investments Commission (ASIC) regulations mandating quarterly portfolio disclosures for exchange‑traded funds (ETFs).
  • Investor Transparency: The routine nature of the filing ensures that stakeholders receive timely information regarding the fund’s asset allocation, risk profile, and hedging strategies.

Practical Implications for Investors and Healthcare Professionals

  • Investment Impact: For investors focused on the healthcare sector, the modest holding in Sonic Healthcare offers limited direct exposure. However, the fund’s broader Australian focus may still provide indirect exposure to the healthcare industry through other Australian equities.
  • Risk Considerations: Currency hedging can reduce volatility but introduces counterparty risk and potential costs associated with forward contracts. Investors should assess whether the hedge aligns with their risk tolerance and currency exposure objectives.
  • Healthcare System Perspective: Although the fund’s disclosure does not delve into the operational or clinical performance of Sonic Healthcare, stakeholders in the healthcare system may interpret the fund’s limited stake as an indicator of broader market sentiment toward the diagnostics sector.

Conclusion

The March 2026 portfolio update underscores the Intelligent Investor Equity Growth Fund’s continued emphasis on Australian equities, complemented by selective international exposure and active currency risk management. While the disclosure does not provide detailed commentary on Sonic Healthcare’s performance or strategic direction, it furnishes essential information on the fund’s asset allocation and hedging mechanisms, enabling informed decision‑making for both investors and professionals monitoring market dynamics within the healthcare sector.